Sartorius AG (SRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
Apr 26, 2023: Sartorius and va-Q-tec announce a long-term partnership for the joint development of innovative transport systems for the biopharmaceutical industry
Apr 20, 2023: Sartorius announces Q1 2023 financial results
Mar 29, 2023: Annual General Meeting of Sartorius AG: Dynamic market with many growth opportunities
The profile contains critical company information including:
- Business description - A detailed description of the company's operations and business divisions.
- Corporate strategy - Analyst's summarization of the company's business strategy.
- SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Sartorius AG (Sartorius) manufactures and distributes laboratory and process technology equipment. The company's lab product portfolio includes laboratory instruments such as pipettes, laboratory water purification systems, weight sets, and lab balances. It provides bioprocess solutions for efficient biologic manufacture of medications and vaccines. The company also offers a diverse range of products for purification, separation and concentration, and solutions for the storage and transportation of intermediate and final biological products. It serves pharmaceutical, biotechnology, chemical, food and beverage industries, and numerous research and educational institutes and laboratories in Germany and other countries. The company has manufacturing facilities in Europe, Asia-Pacific, and Americas. Sartorius is headquartered in Gottingen, Niedersachsen, Germany.Sartorius AG Key Recent Developments
May 16, 2023: Sartorius : India delivery center openedApr 26, 2023: Sartorius and va-Q-tec announce a long-term partnership for the joint development of innovative transport systems for the biopharmaceutical industry
Apr 20, 2023: Sartorius announces Q1 2023 financial results
Mar 29, 2023: Annual General Meeting of Sartorius AG: Dynamic market with many growth opportunities
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 - About the Company
Section 2 - Company Analysis
Section 3 - Company Financial Ratios
Section 4 - Company’s Lifesciences Financial Deals and Alliances
Section 5 - Company’s Recent Developments
Section 6 - Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- PerkinElmer Inc
- Stratec SE
- Buchi Labortechnik AG
- Eppendorf SE
- Analytik Jena AG
- Pall Corp
- Mettler-Toledo International Inc
- Becton Dickinson and Co
- Agilent Technologies Inc
- Thermo Fisher Scientific Inc
- Merck KGaA
- General Electric Co
- Aenitis Technologies